Quantum Genesis AI Corp

Quantum Genesis AI Corp is a biotransformation company focused on clean and green chemistry, specifically developing engineered enzymes for active pharmaceutical ingredient ("API") production. The company conducts research to enhance enzyme activity, selectivity, and specificity by applying novel quantum mechanics, molecular modeling, and engineering approaches. Quantum Genesis AI Corp aims to aid chemical companies in simplifying complex chemistry and reducing the number of steps by implementing scientific rationale like quantum mechanics in biology. As of the date of this report, Quantum Genesis AI Corp has engineered its first product: an enzyme for use in the pharmaceutical API production of Ibuprofen. This initial product is targeted at select pharmaceutical companies that produce generic drugs. The company is currently identifying third-party manufacturers and distributors capable of large-scale enzyme manufacturing and product distribution within relevant markets. As of the date of this report, Quantum Genesis AI Corp has not filed for patent protection for this product and does not anticipate doing so in the near future, as the associated costs currently outweigh the anticipated benefits.